METHOTREXATE PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
When do Methotrexate Preservative Free patents expire, and when can generic versions of Methotrexate Preservative Free launch?
Methotrexate Preservative Free is a drug marketed by Fresenius Kabi Usa and Hospira and is included in three NDAs.
The generic ingredient in METHOTREXATE PRESERVATIVE FREE is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methotrexate Preservative Free
A generic version of METHOTREXATE PRESERVATIVE FREE was approved as methotrexate sodium by HIKMA on September 16th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHOTREXATE PRESERVATIVE FREE?
- What are the global sales for METHOTREXATE PRESERVATIVE FREE?
- What is Average Wholesale Price for METHOTREXATE PRESERVATIVE FREE?
Summary for METHOTREXATE PRESERVATIVE FREE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Clinical Trials: | 2 |
Patent Applications: | 4,433 |
DailyMed Link: | METHOTREXATE PRESERVATIVE FREE at DailyMed |
Recent Clinical Trials for METHOTREXATE PRESERVATIVE FREE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Pfizer | Early Phase 1 |
EMD Serono | Early Phase 1 |
Aaron Boster | Early Phase 1 |
Pharmacology for METHOTREXATE PRESERVATIVE FREE
Drug Class | Folate Analog Metabolic Inhibitor |
Mechanism of Action | Folic Acid Metabolism Inhibitors |
US Patents and Regulatory Information for METHOTREXATE PRESERVATIVE FREE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | METHOTREXATE PRESERVATIVE FREE | methotrexate sodium | INJECTABLE;INJECTION | 040266-001 | Feb 26, 1999 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hospira | METHOTREXATE PRESERVATIVE FREE | methotrexate sodium | INJECTABLE;INJECTION | 011719-014 | Apr 13, 2005 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fresenius Kabi Usa | METHOTREXATE PRESERVATIVE FREE | methotrexate sodium | INJECTABLE;INJECTION | 040265-001 | Feb 26, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | METHOTREXATE PRESERVATIVE FREE | methotrexate sodium | INJECTABLE;INJECTION | 011719-011 | Apr 13, 2005 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | METHOTREXATE PRESERVATIVE FREE | methotrexate sodium | INJECTABLE;INJECTION | 011719-013 | Apr 13, 2005 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |